phosphatidylcholines has been researched along with nimodipine in 5 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (nimodipine) | Trials (nimodipine) | Recent Studies (post-2010) (nimodipine) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 2,936 | 317 | 597 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | nimodipine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 0.11 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.19 | |
| Cannabinoid receptor 1 | Homo sapiens (human) | 1.736 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 4 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 3.38 | |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | Homo sapiens (human) | 0.0298 | |
| Voltage-dependent L-type calcium channel subunit beta-2 | Homo sapiens (human) | 0.0298 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 7.15 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 0.0699 | |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | 1.243 | |
| Bile acid receptor | Homo sapiens (human) | 8.96 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mason, RP; Moisey, DM; Shajenko, L | 1 |
| Ge, L; Yang, D; Zhang, G; Zheng, Y; Zhu, J | 1 |
| He, HB; Tang, X; Yu, J | 1 |
| Gong, T; Jiang, Y; Ren, C; Song, X; Sun, X; Zhang, Q; Zhang, Z | 1 |
| Basalious, EB; Shamma, RN | 1 |
5 other study(ies) available for phosphatidylcholines and nimodipine
| Article | Year |
|---|---|
Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cattle; Cell Membrane; Cholesterol; Dihydropyridines; Diltiazem; Electrons; Isradipine; Lipid Bilayers; Myocardium; Nifedipine; Nimodipine; Nitrendipine; Phosphatidylcholines; Rabbits; Verapamil | 1992 |
Preparation, characterization, and pharmacokinetics of sterically stabilized nimodipine-containing liposomes.
Topics: Animals; Area Under Curve; Calcium Channel Blockers; Chemistry, Pharmaceutical; Cholesterol; Drug Stability; Freeze Drying; Half-Life; Infusions, Intravenous; Liposomes; Metabolic Clearance Rate; Nimodipine; Particle Size; Phosphatidylcholines; Rabbits | 2006 |
Formulation and evaluation of nimodipine-loaded lipid microspheres.
Topics: Animals; Area Under Curve; Chemistry, Pharmaceutical; Colloids; Drug Stability; Ear; Ethanol; Injections, Intravenous; Male; Microspheres; Nimodipine; Pain Measurement; Particle Size; Phosphatidylcholines; Plant Oils; Rabbits; Rats; Rats, Wistar; Reproducibility of Results; Sodium Chloride; Solubility; Spleen; Tissue Distribution; Vasodilator Agents; Veins | 2006 |
Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study.
Topics: Animals; Drug Stability; Ear; Edema; Glycocholic Acid; Hydrogen-Ion Concentration; Male; Micelles; Nimodipine; Particle Size; Phlebitis; Phosphatidylcholines; Rabbits; Rats; Rats, Wistar; Solubility; Veins | 2012 |
Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies.
Topics: Administration, Oral; Animals; Biological Availability; Biological Transport; Brain; Calcium Channel Blockers; Intestinal Absorption; Male; Micelles; Nanotubes; Nimodipine; Phosphatidylcholines; Poloxalene; Poloxamer; Rats, Wistar; Solubility | 2015 |